Wisdom. Applied.
  • The Firm
  • The Team

Tag: pharmaceutical

Success In Motion | Videocast

Is Someone Else Using Your Medical License? – Success in Motion

Ride along with Mark as he discusses the danger of intentionally or negligently allowing someone else to use your medical license.

Continue Reading...

Kickback | Strategy

Yet Another Physician Guilty of Receiving Insys/Subsys Kickbacks

In general terms, the federal Anti-Kickback Statute (“AKS”) prohibits the offer, demand, payment, and acceptance of remuneration—that is, of anything of value—for referrals.

Continue Reading...

Compliance

$871.9 Million Dollar Pill Proves Hard to Swallow

But what about the rising price of settling allegations of pharmaceutical price-fixing?

Continue Reading...

Compliance

“But Everyone Is Doing It!” Is Not a Great Defense to a Compliance Violation

Many people – physicians and business people – engaging in arrangements involving sophisticated federal and state anti-kickback issues and self-referral issues, often simply point to someone else who is doing what they claim is the same thing, as if that makes it acceptable.

Continue Reading...

Medical Group Minute | Videocast

Compounding the Kickback Problem – Medical Group Minute

Compounding pharmaceuticals, specific drugs for specific patients, offers tremendous benefit. The problems arise when the benefit is for the prescribing physician.

Continue Reading...

Strategy

Former Drug Company CEO Pleads Guilty and Will Cooperate in Upcoming Kickback Scam Prosecution

Former CEO Michael Babich pleaded guilty last week to charges related to the plethora of kickback allegations surrounding Insys Therapeutics, Inc., and its fentanyl drug, Subsys.

Continue Reading...

Success In Motion | Videocast

U.S. Government Intervenes in 5 Kickback Based Whistleblower Cases Against Insys – Success in Motion

Ride along while Mark discusses the expanding case involving Insys Therapeutics and kickbacks paid to induce prescription of its drug, Subsys.

Continue Reading...

Podcast

Drugs, Sentencing and Lock (and Roll on to Another Kickback Prosecution) – Podcast

The federal Anti-Kickback statute makes it illegal to receive anything of value for the referral of federal health care program patients. How are you managing this potential pitfall? Podcast: Play in new window | Download

Continue Reading...

Kickback | Strategy

Another Physician Guilty of Receiving Insys/Subsys Kickbacks

On October 25, 2017, another physician, Jerrold Rosenberg, M.D., pleaded guilty to charges related to the plethora of kickback prosecutions emanating from Insys Therapeutics, Inc., and its fentanyl drug, Subsys. Couch and Ruan Sent to Prison In February of this year, I wrote in my post Pain Medicine Doctors Alleged to Have Received $115,000 in […]

Continue Reading...

Strategy

Drugs, Sentencing, and Lock (and Roll on to Another Kickback Prosecution)

As I comment often, the federal Anti-Kickback statute makes it illegal to receive anything of value for the referral of federal health care program patients.

Continue Reading...

Posts navigation

Older posts
About Mark
About Mark

 
Mark F. Weiss represents large physician groups, highly entrepreneurial physicians, and physicians and others in the development of surgery centers, imaging facilities and other healthcare ventures. The object is success. 

NEW
NEW

Learn strategic tools and insights that you need in order to seize opportunities, whether they’re in the context of your current business relationships, the expansion of your business activities, or the creation of new ventures. 

Others see a crisis and freeze in fear. Learn how to see the opportunities and obtain the tools to increase your odds of obtaining them.

BE THE FIRST TO GET THE LATEST!
Categories
Post Archives
BOOK: The Medical Group Governance Matrix
BOOK: The Medical Group Governance Matrix
BOOK: The Impending Death of Hospitals
BOOK: The Impending Death of Hospitals
©2022 Mark F. Weiss, Principal | Meetings with Mark F. Weiss are by appointment only
Theme by MOOZ Themes Powered by WordPress